Breast Cancer Coverage From Every Angle
Advertisement
Advertisement

Kathy S. Albain, MD, on Breast Cancer, Ethnicity, and Clinical Outcomes: NCCN Perspectives on the TAILORx Trial

Posted: Friday, December 14, 2018

Kathy S. Albain, MD, of Loyola University Stritch School of Medicine, discusses study findings on race, ethnicity, and patient outcomes in hormone receptor–positive, HER2-negative, node-negative breast cancer as they relate to the NCCN Guidelines.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.